FdaApplication
NDA 213969
Identifiers
- fda_app_no: NDA213969
Properties
| Property | Value |
|---|---|
| applicant_name | SENTYNL THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2020-11-20 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZOKINVY | LONAFARNIB | 75MG | CAPSULE;ORAL |
| ZOKINVY | LONAFARNIB | 50MG | CAPSULE;ORAL |
2 products